Skip to main content
. Author manuscript; available in PMC: 2026 Aug 25.
Published in final edited form as: Support Care Cancer. 2025 Apr 8;33(5):362. doi: 10.1007/s00520-025-09392-y

Table 4:

SNPs within 50 kb of candidate genes from 2019 MASCC Neurological Complications Working Group Overview. No SNPs were suggestive of genome wide significance (p-value all greater than <1x10–5), therefore this table is only displaying two SNPs within 50 kb from each gene (lowest two p-values).

CHROMOSOME GENE POSITION ALLELE 0 ALLELE 1 ALLELE 1 FREQUENCY BETA ODDS RATIO HIGHER 95% CI LOWER 95% CI P-VALUE GENE WITHIN 50 KB OF SNP
18 63919403 A C 23% −1.05E-05 1.00 1.29 0.77 2.78E-05 SERPINB2
16 82622189 C T 18% −1.35E-05 1.00 1.31 0.76 3.41E-05 CDH13
4 65396784 A G 25% 2.14E-05 1.00 1.28 0.78 5.93E-05 EPHA5
16 83513791 C T 5% 4.39E-05 1.00 1.63 0.61 6.08E-05 CDH13
8 1919487 T C 6% −8.24E-05 1.00 1.59 0.63 1.21E-04 ARHGEF10
18 53317052 T C 10% −7.17E-05 1.00 1.42 0.70 1.39E-04 DCC
18 53322836 A C 10% −7.17E-05 1.00 1.42 0.70 1.39E-04 DCC
13 95295322 C T 9% −1.05E-04 1.00 1.49 0.67 1.79E-04 ABCC4
2 203897604 G T 21% 8.54E-05 1.00 1.30 0.77 2.20E-04 CTLA4
19 45401800 CA C 24% −8.55E-05 1.00 1.28 0.78 2.35E-04 ERCC1
19 45401800 CA C 24% −8.55E-05 1.00 1.28 0.78 2.35E-04 ERCC2
8 1816739 C A 47% −8.45E-05 1.00 1.23 0.81 2.77E-04 ARHGEF10
4 182810730 A T 16% 1.27E-04 1.00 1.33 0.75 2.99E-04 TENM3
13 95075607 G A 14% −1.59E-04 1.00 1.37 0.73 3.45E-04 ABCC4
4 182348375 C T 5% 2.57E-04 1.00 1.61 0.62 3.69E-04 TENM3
19 43545729 G T 5% 2.67E-04 1.00 1.64 0.61 3.69E-04 XRCC1
1 151835038 G A 17% 1.63E-04 1.00 1.33 0.75 3.87E-04 THEM5
1 151831288 C G 14% −1.96E-04 1.00 1.38 0.72 4.12E-04 THEM5
6 3157554 C T 5% 3.10E-04 1.00 1.62 0.62 4.36E-04 TUBB2A
7 87467135 GTGCTGT G 3% 4.09E-04 1.00 1.80 0.56 4.73E-04 ABCB1
9 104789771 C CCACT 12% 2.48E-04 1.00 1.40 0.72 5.07E-04 ABCA1
12 32451710 C T 16% −2.17E-04 1.00 1.34 0.75 5.09E-04 FGD4
2 221583972 T G 43% 2.03E-04 1.00 1.24 0.81 6.39E-04 EPHA4
7 87568035 G A 38% −2.00E-04 1.00 1.23 0.81 6.53E-04 ABCB1
4 65330904 C A 36% −2.99E-04 1.00 1.26 0.80 8.92E-04 EPHA5
16 70697967 C T 3% −8.58E-04 1.00 1.81 0.55 9.80E-04 VAC14
19 1213879 C T 6% 7.17E-04 1.00 1.60 0.63 1.04E-03 MIDN
12 32538144 T C 30% 3.95E-04 1.00 1.26 0.79 1.16E-03 FGD4
3 96894070 G C 6% 7.72E-04 1.00 1.57 0.64 1.16E-03 EPHA6
3 97100763 A G 19% 4.94E-04 1.00 1.32 0.76 1.23E-03 EPHA6
2 221505338 A T 48% −4.36E-04 1.00 1.24 0.80 1.36E-03 EPHA4
6 170506340 C T 4% 1.09E-03 1.00 1.71 0.59 1.39E-03 PSMB1
15 34261956 G A 34% 4.82E-04 1.00 1.26 0.79 1.40E-03 SLC12A6
19 10297763 A C 7% 8.95E-04 1.00 1.52 0.66 1.45E-03 ICAM1
20 38086209 G C 6% −1.11E-03 1.00 1.62 0.62 1.57E-03 RPRD1B
9 104916516 C T 27% −5.97E-04 1.00 1.28 0.78 1.64E-03 ABCA1
16 70694074 G C 43% −5.34E-04 1.00 1.24 0.81 1.68E-03 VAC14
10 95100709 T G 48% 6.32E-04 1.00 1.24 0.81 2.02E-03 CYP2C8
19 45354988 G A 6% −1.60E-03 1.00 1.67 0.60 2.12E-03 ERCC2
19 45364748 T A 44% 6.76E-04 1.00 1.24 0.81 2.13E-03 ERCC1
20 38059968 C G 19% −9.29E-04 1.00 1.32 0.76 2.29E-03 RPRD1B
2 203894729 A G 16% −1.40E-03 1.00 1.34 0.74 3.22E-03 CTLA4
19 10323992 T C 15% 1.51E-03 1.00 1.35 0.74 3.48E-03 ICAM1
6 170583923 T C 4% −2.75E-03 1.00 1.68 0.59 3.62E-03 PSMB1
10 95004848 A G 3% 3.22E-03 1.00 1.84 0.55 3.62E-03 CYP2C8
15 34285822 T C 27% 1.29E-03 1.00 1.28 0.79 3.62E-03 SLC12A6
6 3138184 A AT 35% 1.30E-03 1.00 1.27 0.79 3.76E-03 TUBB2A
18 63908773 A G 23% −1.51E-03 1.00 1.28 0.78 4.09E-03 SERPINB2
21 43028665 G A 39% −1.40E-03 1.00 1.24 0.80 4.36E-03 PKNOX1
1 109677464 C G 45% 1.58E-03 1.00 1.23 0.82 5.30E-03 GTSM1
19 43533218 C G 17% −2.37E-03 1.00 1.33 0.75 5.69E-03 XRCC1
21 42978791 GT G 5% 4.47E-03 1.00 1.68 0.60 5.94E-03 PKNOX1
11 67623375 A G 13% −2.74E-03 1.00 1.36 0.73 5.99E-03 GSTP1
11 67623890 A C 13% −2.74E-03 1.00 1.36 0.73 5.99E-03 GSTP1
19 1254123 G A 41% −2.03E-03 1.00 1.24 0.80 6.42E-03 MIDN
6 35412221 G A 13% −3.82E-03 1.00 1.38 0.72 8.08E-03 PPARD
1 109665467 A T 37% −2.52E-03 1.00 1.23 0.81 8.34E-03 GTSM1
1 52591811 G A 27% −3.38E-03 1.00 1.27 0.78 9.62E-03 GPX7
6 35311019 C A 20% 4.24E-03 1.00 1.31 0.77 1.09E-02 PPARD
5 664090 C CG 12% 5.58E-03 1.01 1.41 0.72 1.15E-02 CEP72
1 52630054 T C 10% 6.19E-03 1.01 1.45 0.70 1.17E-02 GPX7
7 99609320 A C 6% 8.49E-03 1.01 1.62 0.63 1.23E-02 CYP3A5
5 87437561 A G 3% 1.18E-02 1.01 1.89 0.54 1.31E-02 CCNH
5 669327 G A 3% −1.23E-02 0.99 1.87 0.52 1.32E-02 CEP72
7 99642556 A G 10% 9.04E-03 1.01 1.48 0.69 1.64E-02 CYP3A5
5 87375153 T C 47% −1.16E-02 0.99 1.23 0.79 3.70E-02 CCNH